Ezetimibe Impurity 71, with the CAS number 2191318-99-5, is a chemical compound associated with the pharmaceutical agent ezetimibe, which is primarily used to lower cholesterol levels by inhibiting the absorption of cholesterol in the intestines. While specific characteristics of Ezetimibe Impurity 71 may not be widely documented, impurities in pharmaceutical compounds typically arise during the synthesis process and can affect the purity and efficacy of the final product. Such impurities may exhibit distinct physical and chemical properties, including solubility, stability, and reactivity, which can influence their behavior in biological systems. The identification and characterization of impurities like Ezetimibe Impurity 71 are crucial for quality control in drug manufacturing, ensuring that the final pharmaceutical product meets safety and efficacy standards. Analytical techniques such as chromatography and mass spectrometry are often employed to characterize these impurities, providing insights into their structure and potential impact on drug performance.

Ezetimibe Impurity 71

2191318-99-5: Ezetimibe Impurity 71, with the CAS number 2191318-99-5, is a chemical compound associated with the pharmaceutical agent ezetimibe, which is primarily used to lower cholesterol levels by inhibiting the absorption of cholesterol in the intestines. While specific characteristics of Ezetimibe Impurity 71 may not be widely documented, impurities in pharmaceutical compounds typically arise during the synthesis process and can affect the purity and efficacy of the final product. Such impurities may exhibit distinct physical and chemical properties, including solubility, stability, and reactivity, which can influence their behavior in biological systems. The identification and characterization of impurities like Ezetimibe Impurity 71 are crucial for quality control in drug manufacturing, ensuring that the final pharmaceutical product meets safety and efficacy standards. Analytical techniques such as chromatography and mass spectrometry are often employed to characterize these impurities, providing insights into their structure and potential impact on drug performance.

CAS 2191318-99-5

Ezetimibe Impurity 71

Ezetimibe Impurity 32

Ref: 4Z-E-0639

Ezetimibe Impurity 11

Ref: ST-EA-CP-E6073